53408-71-2

1,2,3-propanetricarboxylate, 2-hydroxy-, curium salt

1,2,3-propanetricarboxylate, 2-hydroxy-, curium salt

Catalog No.2109425
Name 1,2,3-propanetricarboxylate, 2-hydroxy-, curium salt
CAS53408-71-2
FormulaC6H5CmO7
Boiling Point155.2 ( ℃ )

Request a Quote

Structure of 53408-71-2

About 1,2,3-propanetricarboxylate, 2-hydroxy-, curium salt

1,2,3-propanetricarboxylate, 2-hydroxy-, curium salt is a chemical compound registered under CAS number 53408-71-2, with the molecular formula C6H5CmO7 and a molecular weight of about 436.17 g/mol. KingPharm Group supplies 1,2,3-propanetricarboxylate, 2-hydroxy-, curium salt for laboratory research and bulk production; product code 2109425. Send an inquiry for purity, packaging, price and lead time.

CAS Number
53408-71-2
Molecular Formula
C6H5CmO7
Molecular Weight
436.17 g/mol

Related Products

  1. 4-Oxazolamine,5-ethyl-2,5-dihydro-N,N-dimethyl-5-phenyl-2-(phenylimino)-
    68980-29-0
  2. 5-Pyrimidinecarboxamide,2-[[2-(4-hydroxyphenyl)ethyl]amino]-4-[[3-[2-(4-morpholinyl)ethyl]phenyl]amino]-, dihydrochloride
    643089-33-2
  3. 4-Quinolinamine,1-(4-chlorobenzoyl)-1,2,3,4-tetrahydro-2,6-dimethyl-N-(4-methylphenyl)-, (2R,4R)-rel-
    637005-90-4
  4. 4-Piperidinecarboxylic acid, 1-[(4-oxo-1-piperidinyl)carbonyl]-, ethylester
    392630-89-6
  5. 5H-[1]Benzopyrano[3,4-b]pyridine, 10-methoxy-1-methyl-
    659745-60-5
  6. 4-Piperidinecarbonitrile, 4-(4-chlorophenyl)-1-(phenylmethyl)-
    214848-52-9
  7. Stannane, trimethyl[(1Z)-2-methyl-1,3-butadienyl]-
  8. 4-ethyl-2-methylheptan-2-amine (2E)-but-2-enedioate
  9. 4-Thiazolemethanol, 2-[[[(1,1-dimethylethyl)diphenylsilyl]oxy]methyl]-
  10. Triphosphoric acid, P-(2-hydroxy-3-methyl-3-butenyl) ester, tetrasodiumsalt
  11. 53408-71-2 msds
  12. CAS No 53408-71-2 supplier
  13. CASNo 53408-71-2 distributor
  14. CAS # 53408-71-2 manufacturer
  15. CAS Number 53408-71-2 safety
  16. CAS RN 53408-71-2 wholesale
  17. 2026-10-23 Find 1,2,3-propanetricarboxylate, 2-hydroxy-, curium salt,CAS No.53408-71-2,Formula:C6H5CmO7 in KingPharm Group